IACCARINO, Guido
 Distribuzione geografica
Continente #
NA - Nord America 14.672
AS - Asia 11.211
EU - Europa 4.210
SA - Sud America 777
Continente sconosciuto - Info sul continente non disponibili 467
AF - Africa 120
OC - Oceania 5
Totale 31.462
Nazione #
US - Stati Uniti d'America 14.485
HK - Hong Kong 6.520
SG - Singapore 2.059
IT - Italia 1.644
CN - Cina 1.004
VN - Vietnam 721
UA - Ucraina 710
BR - Brasile 616
DE - Germania 386
RU - Federazione Russa 385
TR - Turchia 245
IE - Irlanda 230
FR - Francia 210
FI - Finlandia 183
KR - Corea 182
SE - Svezia 181
IN - India 106
BD - Bangladesh 96
GB - Regno Unito 96
CA - Canada 73
AR - Argentina 60
MX - Messico 55
JP - Giappone 43
PL - Polonia 38
IQ - Iraq 33
NL - Olanda 33
ZA - Sudafrica 33
ES - Italia 30
PK - Pakistan 27
EC - Ecuador 25
ID - Indonesia 23
EU - Europa 20
VE - Venezuela 20
UZ - Uzbekistan 19
JM - Giamaica 17
PH - Filippine 17
AT - Austria 16
MY - Malesia 16
SA - Arabia Saudita 16
JO - Giordania 15
KE - Kenya 14
PY - Paraguay 14
TN - Tunisia 14
CZ - Repubblica Ceca 13
CL - Cile 12
CO - Colombia 12
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
MA - Marocco 9
CH - Svizzera 8
CR - Costa Rica 8
EG - Egitto 7
NP - Nepal 7
AL - Albania 6
BO - Bolivia 6
HN - Honduras 6
IL - Israele 6
KZ - Kazakistan 6
PE - Perù 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
ET - Etiopia 5
KG - Kirghizistan 5
LT - Lituania 5
AO - Angola 4
BE - Belgio 4
BS - Bahamas 4
CI - Costa d'Avorio 4
GR - Grecia 4
NG - Nigeria 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
AU - Australia 3
BG - Bulgaria 3
GE - Georgia 3
GH - Ghana 3
LU - Lussemburgo 3
MK - Macedonia 3
NI - Nicaragua 3
OM - Oman 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BB - Barbados 2
GT - Guatemala 2
GY - Guiana 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
YT - Mayotte 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 30.988
Città #
Hong Kong 6.507
Ann Arbor 2.883
Wilmington 2.394
Singapore 1.090
San Jose 967
Jacksonville 885
Woodbridge 855
Chandler 846
Princeton 691
Milan 592
Houston 578
Ashburn 483
Dallas 463
Council Bluffs 405
Dong Ket 307
Dublin 230
Beijing 215
The Dalles 210
Izmir 205
Lauterbourg 185
Rome 160
Nanjing 159
Andover 158
Boardman 158
Pellezzano 138
Ho Chi Minh City 137
Mestre 135
Moscow 124
Los Angeles 110
Santa Clara 100
Dearborn 97
Salerno 90
Hanoi 89
Munich 88
New York 86
Düsseldorf 80
Fairfield 71
São Paulo 59
Changsha 56
Shenyang 53
Figino 48
Hebei 44
Falls Church 42
Nanchang 42
Memphis 41
Tokyo 41
Turin 41
Orem 37
Warsaw 33
Jiaxing 32
Saint Petersburg 32
Napoli 31
Norwalk 31
San Francisco 30
Montreal 29
Brooklyn 28
Phoenix 26
San Diego 26
Mexico City 25
Turku 25
Denver 24
London 24
Naples 24
Tianjin 24
Atlanta 23
Rio de Janeiro 23
Venezia 23
Johannesburg 22
Chennai 21
Frankfurt am Main 20
Nuremberg 20
Stockholm 20
Manchester 19
Jinan 18
Chicago 17
Columbus 17
Grevenbroich 17
Redwood City 17
Tashkent 17
Washington 17
Buffalo 16
Charlotte 16
Da Nang 16
Haiphong 16
Cambridge 15
Guangzhou 15
Pune 15
Seattle 14
Shanghai 14
Poplar 13
Seoul 13
Amman 12
Amsterdam 12
Baghdad 12
Biên Hòa 12
Nairobi 12
Curitiba 11
Helsinki 11
Lappeenranta 11
Mumbai 11
Totale 24.497
Nome #
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control 896
Serum uric acid predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 863
Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the Beta adrenergic system. 578
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. 528
Insulin-induced changes in beta-adrenergic response: an experimental study in the isolated rat papillary muscle. 502
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 438
"Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors 438
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 314
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 313
Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease. 310
Mitochondrial Localization Unveils a Novel Role for Grk2 in the Regulation of Oxidative Metabolism 310
Adrenergic signaling in heart failure and cardiovascular aging 294
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 285
G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. 277
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. 264
Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. 259
Serum uric acid and left ventricular mass in essential hypertension 258
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 248
Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats. 248
Thyroid function predicts increased cardiovascular risk 241
Characterization of a selective CaMKII peptide inhibitor 229
Vitamin D, parathyroid hormone and cardiovascular risk: The good, the bad and the ugly 225
Cellular subtype expression and activation of CaMKII regulate the fate of atherosclerotic plaque 224
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy 216
Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. 213
Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. 213
To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator 213
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 206
A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity. 206
AKT participates in endothelial dysfunction in hypertension. 199
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice 199
Influence of digitalis on left ventricular functional response to exercise in congestive heart failure. 198
L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome. 195
Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension. 191
Age-Related Impairment in Insulin Release: The Essential Role of β2-Adrenergic Receptor. 189
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. 187
A Novel CaMKII/ERK Interaction n the Heart Sustains Cardiac Hypertrophy in Spontaneously Hypertensive Rats 183
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. 181
GRK2 endothelial deletion causes hypotension and defective vasoconstriction in Tie2-CRE/GRK2fl/fl transgenic mice 174
Targeting myocardial remodelling to develop novel therapies for heart failure 174
Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. 171
Cardiotoxic effects of short-term doxorubicin administration: Involvement of connexin 43 in calcium impairment 171
G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. 170
Operational Definition of Active and Healthy Aging (AHA): The European Innovation Partnership (EIP) on AHA Reference Site Questionnaire: Montpellier October 20-21, 2014, Lisbon July 2, 2015 169
Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity 169
Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. 168
Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis 167
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 167
A novel CaMKII/ERK interaction in the heart sustains cardiac hypertrophy in spontaneously hypertensive rats 165
Mitochondrial G protein coupled receptor kinase 2 regulates proinflammatory responses in macrophages. 164
The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension. 163
Acute noradrenergic activation induces insulin resistance in human skeletal muscle 162
Active and Healthy Ageing and Independent Living 2016 162
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 161
G beta gamma-mediated signaling: new therapeutic target for proliferative vascular disease. 161
Active and Healthy Ageing and Independent Living 160
Transgenic mice targeting the heart unveil G protein-coupled receptor kinases as therapeutic targets. 160
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 159
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. 158
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling. 158
A POLYMORPHISM WITHIN THE PROMOTER OF THE DOPAMINE RECEPTOR D1 (DRD1-48A/G) ASSOCIATES WITH IMPAIRED KIDNEY FUNCTION IN WHITE HYPERTENSIVE PATIENTS 157
Association Study on Long-Living Individuals from Southern Italy Identifies rs10491334 in the CAMKIV Gene That Regulates Survival Proteins. 157
Microwave-Assisted Synthesis of KN-93, a Potent and Selective Inhibitor of Ca2+/Calmoduline-Dependent Protein Kinase II 156
The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. 156
The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis 155
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 155
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 152
Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. 151
ADRENERGIC MECHANISM IN THE CONTROL OF ENDOTHELIAL FUNCTION 149
Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. 149
Redesigning service delivery for hypertensive patients: a methodological guideline to improve the management of chronic diseases 148
Endothelial g protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species. 146
[Non-hemodynamic mechanisms of cardiovascular risk in the hypertensive patient: insulin resistance]. 145
Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor 144
CaMK4 Gene Deletion Induces Hypertension 143
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. 143
Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. 143
Myocardial G protein-coupled receptor kinases: implications for heart failure therapy. 142
External support modulates G protein expression and receptor coupling in experimental vein grafts. 142
Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans. 141
Good at Heart: Preserving Cardiac Metabolism during aging 141
Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. 141
Insufficient control of blood pressure and incident diabetes. 140
The crosstalk between insulin and the sympathetic nervous system: possible implications in the pathogenesis of essential hypertension. 139
G Protein-Coupled Receptor Kinases and Hypertension 138
New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling 138
Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. 137
P501 * GRK2 inhibition with small peptide improves cardiac function during heart failure 137
Operational definition of Active and Healthy Ageing (AHA): A conceptual framework 137
Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization 137
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. 137
Atrial fibrillation and microRNAs 137
CaMKII protects MKP-1 from proteasome degradation in endothelial cells. 136
Enhanced Expression of ss3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling through Nitric Oxide Synthase. 135
The mechanisms of air pollution and particulate matter in cardiovascular diseases 135
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models. 134
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes 134
Insulin modulation of beta-adrenergic vasodilator pathway in human forearm. 132
Adenoviral-mediated inhibition of Gβγ signaling limits the hyperplastic response in experimental vein grafts 132
New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53 131
Totale 20.866
Categoria #
all - tutte 94.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.233 0 0 5 11 62 45 16 60 183 167 150 534
2022/20231.960 209 124 28 231 282 415 8 207 312 2 101 41
2023/2024728 99 105 33 36 42 67 26 44 13 55 26 182
2024/20252.001 82 28 18 68 91 310 248 214 330 131 235 246
2025/202613.908 1.316 3.436 2.799 475 955 551 1.471 316 505 822 266 996
2026/2027772 314 272 186 0 0 0 0 0 0 0 0 0
Totale 31.462